Ultrathin bioresorbable polymer sirolimus-eluting stents versus thin durable polymer everolimus-eluting stents

DE Kandzari, JJ Koolen, G Doros, JJ Massaro… - Journal of the American …, 2018 - jacc.org
Background: Coronary drug-eluting stent development has introduced new metal alloys,
changes in stent architecture, and bioresorbable polymers. Whether these advancements …

Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents

DE Kandzari, JJ Koolen, G Doros, JJ Massaro… - 2018 - pubmed.ncbi.nlm.nih.gov
Background Coronary drug-eluting stent development has introduced new metal alloys,
changes in stent architecture, and bioresorbable polymers. Whether these advancements …

[HTML][HTML] Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents

DE Kandzari, JJ Koolen, G Doros, JJ Massaro… - Journal of the American …, 2018 - Elsevier
Background Coronary drug-eluting stent development has introduced new metal alloys,
changes in stent architecture, and bioresorbable polymers. Whether these advancements …

Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents.

DE Kandzari, JJ Koolen, G Doros… - Journal of the …, 2018 - europepmc.org
Background Coronary drug-eluting stent development has introduced new metal alloys,
changes in stent architecture, and bioresorbable polymers. Whether these advancements …

[引用][C] Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents

DE Kandzari, JJ Koolen, G Doros, JJ Massaro… - Journal of the American …, 2018 - cir.nii.ac.jp
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer
Everolimus-Eluting Stents | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

[PDF][PDF] Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents

DE Kandzari, JJ Koolen, G Doros… - JOURNAL OF THE …, 2018 - lirias.kuleuven.be
ABSTRACT BACKGROUND Coronary drug-eluting stent development has introduced new
metal alloys, changes in stent architecture, and bioresorbable polymers. Whether these …